Navigation Links
New Book Chapter from CEM on Microwave Peptide Synthesis
Date:6/11/2013

MATTHEWS, N.C., June 11, 2013 /PRNewswire/ -- CEM Corporation, a leading global provider of microwave laboratory instrumentation is pleased to announce its contribution of a new chapter on microwave peptide synthesis, which appears in Microwaves in Organic Synthesis, Volume 2, Third Edition, edited by Professor Antonio de la Hoz and Dr. Andre Loupy.

(Logo: http://photos.prnewswire.com/prnh/20090622/CL35336LOGO-b)

The chapter entitled, "Microwave-Enhanced Synthesis of Peptides, Proteins and Peptidomimetics," was authored by Jonathan M. Collins, the initial developer of CEM's microwave peptide synthesis technology, and offers an in-depth discussion of the theory, technology, and chemistry behind incorporating microwave energy into peptide synthesis with more than 300 cited references.  It provides a complete overview and analysis of all research to date in this field along with a mechanistic discussion of the common chemistries and side reactions encountered in solid phase peptide synthesis. 

"This chapter is intended to be a useful tool for any researcher using or considering using microwave irradiation for solid phase synthesis of peptides and peptidomimetics," said Jonathan M. Collins, "the field is rapidly evolving and microwave has proven useful for reducing synthesis times as well as in many cases increasing peptide product purity."

Collins, who holds degrees from the University of Florida, Northwestern University, and Stanford University, initiated CEM's movement into microwave peptide synthesis in late 2002. Currently, Director of Business Development for CEM Corporation, Collins continues to research microwave peptide synthesis and develop new methods and technologies to improve the process. In 2013, CEM plans to announce several major developments in microwave peptide synthesis that will continue its leadership position in this field.

Microwaves in Organic Synthesis, Volume 2, Third Edition is currently available from Wiley-Blackwell (DOI: 10.1002/9783527651313.ch20).

CEM Corporation, a private company based in Matthews, North Carolina, is the leading global company specializing in scientific solutions for critical laboratory applications. The Company has subsidiaries in the United Kingdom& Ireland, Germany, Italy, France, and Japan, as well as a global network of distributors. CEM designs and manufactures systems for bioscience applications, life sciences, analytical laboratories and processing plants worldwide. The Company's products are used in many industries including pharmaceutical, biotech, chemical and food processing, as well as academic research.


'/>"/>
SOURCE CEM Corporation
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. All Market Research New Report @ The Worldwide Industry & Regional Market Opportunities With Forecasts to 2016 for Amplifiers and Integrated Microwave Assemblies. (Code name: AIMAs)
2. UCLA-led research team develops worlds most powerful nanoscale microwave oscillators
3. Nature Materials: Quick-cooking nanomaterials in microwave to make tomorrows air conditioners
4. Atlantic Peptides Teams Up with a United Kingdom Company to Offer cGMP Peptides and API
5. Palatin Technologies Announces Notification of Patent Allowance On Melanocortin Receptor-Specific Peptides for Sexual Dysfunction
6. Aurigene Highlights its PD-1 peptide, Bet Bromodomain and NAMPT Inhibitors Program at AACR 2013
7. Peptide Therapeutics Market is Expected to Reach USD 25.4 Billion Globally in 2018: Transparency Market Research
8. Waters Unveils Industrys First Integrated LC/MS Platform for Proteins, Peptides, and Glycans Analysis at WCBP 2013
9. Small peptide ameliorates autoimmune skin blistering disease in mice
10. US Patent awarded for using Metal Peptides to Help Diminish Skin Imperfections
11. Strategic Analysis of the Collagen Peptide Market in the United States
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/23/2017)... , March 23, 2017  GlobeImmune, Inc. today announced ... the sale of 12,835,490 shares of its common stock ... of companies. In connection with the sale of its common ... cash and issue to GlobeImmune 200,000 shares, an estimated ... "We are pleased to enter into this ...
(Date:3/23/2017)... SEATTLE , March 23, 2017 ... translational development of novel therapies in immuno-oncology, today ... to lead" small molecule compounds that activate interferon ... (RLR) pathways and demonstrate immune-mediated tumor regression in ... in the study who demonstrated complete tumor regression ...
(Date:3/23/2017)... March 23, 2017  Agriculture technology company Cool Planet ... and note conversion to commercialize its Cool Terra and ... on developing products that are simultaneously profitable as well ... the last 18 months. This latest round of funding ... Partners. The company,s primary product, Cool ...
(Date:3/22/2017)... March 22, 2017 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN), ... Center (RGC), U.K. Biobank and GSK to generate genetic sequence ... resource. The initiative will enable researchers to gain valuable insights ... a wide range of serious and life threatening diseases. ... Genetic evidence ...
Breaking Biology Technology:
(Date:2/21/2017)... PORTLAND, Ore. , Feb. 22, 2017  IBM ... Companies (Avamere Health Services, Infinity Rehab, Signature Hospice, Home ... that will apply the power of IBM cognitive computing ... health centers. By analyzing data streaming from sensors in ... physical and environmental conditions, and obtain deeper learnings into ...
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
Breaking Biology News(10 mins):